Immunotherapy 2.0 Named Advance of the Year in ASCO’s Report

February 1st, 2017 – A growing number of patients with cancer are benefiting from research advances in immunotherapy, leading ASCO to name immunotherapy as the Society’s Advance of the Year for a second year in a row. Released today, Clinical Cancer Advances 2017: ASCO’s Annual Report on Progress Against Cancer highlights the expanding role of immunotherapy. Evolving research findings are providing new insights on how to get optimal … (leggi tutto)